Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical safety interaction of M1150C1 with tacrolimus ointment in adults with atopic dermatitis
jRCT1080225219Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tacrolimus in atopic dermatitis (AD) (2 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Local topical safety after single tacrolimus application with M1150C1 vs white petrolatum pretreatment. Started Jun 2020; status: completed.
02
Drugs
tacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1080225219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225219.